RISKGUARD HEREDITARY CANCER TEST Trademark
Trademark Overview
On Friday, November 22, 2024, a trademark application was filed for RISKGUARD HEREDITARY CANCER TEST with the United States Patent and Trademark Office. The USPTO has given the RISKGUARD HEREDITARY CANCER TEST trademark a serial number of 98868555. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, November 22, 2024. This trademark is owned by Exact Sciences Corporation. The RISKGUARD HEREDITARY CANCER TEST trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Medical & Beauty Services & Agricultural Services categories with the following description:
Preparations for detecting genetic predispositions for medical purposes, namely, hereditary cancer screening test comprised of molecular diagnostic reagents and assays for use in disease detection by detecting DNA, chromosomal changes, abnormalities or mutations for detection of genes for hereditary cancer, identifying hereditary risk associated with cancer and identifying predisposition to cancer; Reagents and assays for medical use; Medical diagnostic reagents; Medical diagnostic assays for use in disease detection and screening related to cancer
Medical testing services, namely, genetic testing and next generation sequencing test for diagnosis and treatment of cancer featuring detection of genes for hereditary cancer, identification of hereditary risk associated with cancer and identification of predisposition to cancer
Diagnostic apparatus for the detection of cancer by detecting genes for hereditary cancer, identifying hereditary risk associated with cancer and identifying predisposition to cancer; Apparatus for collecting biological samples for use in the detection of cancer and pre-cancer for medical purposes by detecting genes for hereditary cancer, identifying hereditary risk associated with cancer and identifying predisposition to cancer; Containers for collecting biological samples for use in the detection of cancer and pre-cancer for medical purposes by detecting genes for hereditary cancer, identifying hereditary risk associated with cancer and identifying predisposition to cancer
General Information
| Serial Number | 98868555 |
| Word Mark | RISKGUARD HEREDITARY CANCER TEST |
| Filing Date | Friday, November 22, 2024 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Friday, November 22, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 0 - NOT AVAILABLE |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of the stylized mark RISKGUARD HEREDITARY CANCER TEST, stacked. |
| Goods and Services | Preparations for detecting genetic predispositions for medical purposes, namely, hereditary cancer screening test comprised of molecular diagnostic reagents and assays for use in disease detection by detecting DNA, chromosomal changes, abnormalities or mutations for detection of genes for hereditary cancer, identifying hereditary risk associated with cancer and identifying predisposition to cancer; Reagents and assays for medical use; Medical diagnostic reagents; Medical diagnostic assays for use in disease detection and screening related to cancer |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Medical testing services, namely, genetic testing and next generation sequencing test for diagnosis and treatment of cancer featuring detection of genes for hereditary cancer, identification of hereditary risk associated with cancer and identification of predisposition to cancer |
| Goods and Services | Diagnostic apparatus for the detection of cancer by detecting genes for hereditary cancer, identifying hereditary risk associated with cancer and identifying predisposition to cancer; Apparatus for collecting biological samples for use in the detection of cancer and pre-cancer for medical purposes by detecting genes for hereditary cancer, identifying hereditary risk associated with cancer and identifying predisposition to cancer; Containers for collecting biological samples for use in the detection of cancer and pre-cancer for medical purposes by detecting genes for hereditary cancer, identifying hereditary risk associated with cancer and identifying predisposition to cancer |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, November 22, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, November 22, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, November 22, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Exact Sciences Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Madison, WI 53719 |
Trademark Events
| Event Date | Event Description |
| Friday, November 22, 2024 | NEW APPLICATION ENTERED |
